Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine plus steroids with or without Myfortic for extensive chronic graft-versus-host disease
2005-006178-86Phase 3Terminated
- Sponsor
- EBMT
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic graft-versus-host disease (cGVHD) comparing Cyclosporine + prednisone + Myfortic with Cyclosporine + prednisone + placebo (2 arms). Primary endpoint: Efficacy success at 1 year. Started Feb 2007; status: terminated.
02
Drugs
mycophenolate sodium
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on 2005-006178-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006178-86.